Journal
Journal of Experimental Medicine
Publication Date
2021
Volume
218
Issue
8
First Page
e20202512
Document Type
Open Access Publication
DOI
10.1084/jem.20202512
Rights and Permissions
J. Justin Milner, Clara Toma, Sara Quon, Kyla Omilusik, Nicole E. Scharping, Anup Dey, Miguel Reina-Campos, Hongtuyet Nguyen, Adam J. Getzler, Huitian Diao, Bingfei Yu, Arnaud Delpoux, Tomomi M. Yoshida, Deyao Li, Jun Qi, Adam Vincek, Stephen M. Hedrick, Takeshi Egawa, Ming-Ming Zhou, Shane Crotty, Keiko Ozato, Matthew E. Pipkin, Ananda W. Goldrath; Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection. J Exp Med 2 August 2021; 218 (8): e20202512. doi: https://doi.org/10.1084/jem.20202512. © 2021 Milner et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
Recommended Citation
Milner, J. Justin; Egawa, Takeshi; and et al, "Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection." Journal of Experimental Medicine. 218, 8. e20202512 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10395
Table S1 lists summary Z-scores from in vivo RNAi screening approach
